Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Diana Crestan, Marta Paulina Trojniak, Sara Francescon, Giulia Fornasier & Paolo Baldo. (2020) Pharmacovigilance of anti-cancer medicines: opportunities and challenges. Expert Opinion on Drug Safety 19:7, pages 849-860.
Read now
Read now
Pawel Robak & Tadeusz Robak. (2017) Novel synthetic drugs currently in clinical development for chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 26:11, pages 1249-1265.
Read now
Read now
Articles from other publishers (6)
Tamiris Lameira Bittencourt, Rhana Berto da Silva Prata, Bruno Jorge de Andrade Silva, Mayara Garcia de Mattos Barbosa, Margareth Pretti Dalcolmo & Roberta Olmo Pinheiro. (2021) Autophagy as a Target for Drug Development Of Skin Infection Caused by Mycobacteria. Frontiers in Immunology 12.
Crossref
Crossref
Tobias Litzenburger, Jürgen Steffgen, Ewald Benediktus, Fabian Müller, Armin Schultz, Elliott Klein, Meera Ramanujam, Christian Harcken, Alpana Gupta, Jing Wu, Sabrina Wiebe, Xiujiang Li, Mary Flack, Steven J. Padula, Sudha Visvanathan, Andreas Hünnemeyer & Jianan Hui. (2020) Safety, pharmacokinetics and pharmacodynamics of BI 705564, a highly selective, covalent inhibitor of Bruton's tyrosine kinase, in Phase I clinical trials in healthy volunteers. British Journal of Clinical Pharmacology 87:4, pages 1824-1838.
Crossref
Crossref
Grigorios Thermos & Konstantinos I. Tosios. (2020) Ibrutinib-associated oral ulcers. Oral Oncology 100, pages 104445.
Crossref
Crossref
Emmanuelle Vigarios, Marie Beylot‐Barry, Marie‐Hélène Jegou, Luice Oberic, Loïc Ysebaert & Vincent Sibaud. (2018) Dose‐limiting stomatitis associated with ibrutinib therapy: a case series. British Journal of Haematology 185:4, pages 784-788.
Crossref
Crossref
Paolo Strati, Alessandra Ferrajoli, William G. Wierda, Nitin Jain, Philip A. Thompson, Susan M. O’Brien, Katy Rezvani, Hagop M. Kantarjian, Jan A. Burger, Christina O. Hinojosa, Michael J. Keating & Zeev Estrov. (2018) Sustained long-lasting responses after lenalidomide discontinuation in patients with chronic lymphocytic leukemia. Leukemia 32:10, pages 2278-2281.
Crossref
Crossref
Khalid M Dousa, Ahmed Babiker, Daniel Van Aartsen, Neel Shah, Robert A Bonomo, John L Johnson & Marion J Skalweit. (2018) Ibrutinib Therapy and Mycobacterium chelonae Skin and Soft Tissue Infection. Open Forum Infectious Diseases 5:7.
Crossref
Crossref